At this time, posts about iCure are rapidly increasing on portals and stock communities, while foreign investors are tentatively estimated to have net sold 27,000 shares today. iCure is known as a company possessing core technology for transdermal drug delivery systems.


As of 1:30 PM on the 10th, iCure's stock price is 71,600 KRW, up 2.14% from the previous day, with a trading volume of 692,371 shares, which is 195.16% of the 5-day average trading volume.


In addition to iCure, posts by investors are also surging for HMM (011200), Korea & Company (000240), and Y&Tech (067900).



※Source: AI Investment Assistant AI Racciro


※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing